We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gene Therapy Creates Pacemakers in Guinea Pigs

By Biotechdaily staff writers
Posted on 26 Sep 2002
Using gene therapy, scientists have been able to convert a small fraction of heart muscle cells in guinea pigs into specialized "pacing” cells that work like biologic pacemakers, paving the way for a genetically engineered alternative to implanted electronic pacemakers. More...
The research was reported in the September 12, 2002, issue of Nature.

In most heart muscle cells, a special channel maintains a balance of potassium that makes it more difficult for them to "fire,” so instead of generating electricity on their own, they must be triggered by pacemaker cells. When these cells stop working or die, an implanted electronic pacemaker can keep the heartbeat going.

Scientists at Johns Hopkins University (Baltimore, MD, USA; www.jhmi.edu) decided that altering the potassium balance might allow heart cells to regain the ability to fire without being triggered. They attached the gene for a defective potassium channel to a virus, adding green fluorescent protein so infected cells could be easily identified, and injected the gene-carrying virus into the heart muscle of guinea pigs. Three to four days later, the heart cells had begun to make the defective potassium channel, and a new, faster pace-setting impulse was clearly visible on electrocardiograms from the animals.

"We've created a biologic pacemaker in the guinea pig, but now the hard work comes,” says Eduardo Marban, M.D., Ph.D., professor at Hopkins' Institute of Molecular Cardiology. "We need to fine tune it: develop controlling strategies, find the optimum place to re-engineer the cells in the heart, and control the frequency of the new pacemaker.”




Related Links:
Johns Hopkins

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Portable POCT Blood Gas Analyzer
BD100
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.